Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress
- PMID: 11668021
- DOI: 10.1152/ajpgi.2001.281.5.G1135
Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress
Abstract
Oxidative stress is present in the liver of humans with steatosis and nonalcoholic steatohepatitis (NASH) and is a plausible mediator of cellular injury, inflammatory recruitment, and fibrogenesis. CYPs 2E1 and 4A are the microsomal oxidases involved with fatty acid oxidation. Both enzymes can reduce molecular oxygen to produce prooxidant species, which, if not countered efficiently by antioxidants, create oxidative stress. In this theme article, we present the evidence that, in the context of hepatic steatosis, CYPs 2E1 and 4A could generate the "second hit" of cellular injury, particularly when antioxidant reserves are depleted, and propose ways in which this could contribute to the pathogenesis of NASH.
Similar articles
-
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.J Clin Invest. 2000 Apr;105(8):1067-75. doi: 10.1172/JCI8814. J Clin Invest. 2000. PMID: 10772651 Free PMC article.
-
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.Hepatology. 1998 Jan;27(1):128-33. doi: 10.1002/hep.510270121. Hepatology. 1998. PMID: 9425928
-
Etiopathogenesis of nonalcoholic steatohepatitis.Semin Liver Dis. 2001;21(1):27-41. doi: 10.1055/s-2001-12927. Semin Liver Dis. 2001. PMID: 11296694 Review.
-
[Pathogenesis of non-alcoholic fatty liver].Z Gastroenterol. 2001 May;39(5):441-2. doi: 10.1055/s-2001-13706. Z Gastroenterol. 2001. PMID: 11413919 German. No abstract available.
-
[Role of oxidative stress in non-alcoholic steatohepatitis].Nihon Rinsho. 2006 Jun;64(6):1077-82. Nihon Rinsho. 2006. PMID: 16768112 Review. Japanese.
Cited by
-
Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease.Hepatol Int. 2008 Jun;2(2):202-8. doi: 10.1007/s12072-008-9060-7. Epub 2008 Feb 27. Hepatol Int. 2008. PMID: 19669305 Free PMC article.
-
Molecular pathways of nonalcoholic fatty liver disease development and progression.Cell Mol Life Sci. 2019 Jan;76(1):99-128. doi: 10.1007/s00018-018-2947-0. Epub 2018 Oct 20. Cell Mol Life Sci. 2019. PMID: 30343320 Free PMC article. Review.
-
CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling.Arch Biochem Biophys. 2007 Mar 1;459(1):59-69. doi: 10.1016/j.abb.2006.10.028. Epub 2006 Nov 2. Arch Biochem Biophys. 2007. PMID: 17222385 Free PMC article.
-
Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.Metab Brain Dis. 2011 Dec;26(4):253-67. doi: 10.1007/s11011-011-9261-y. Epub 2011 Sep 1. Metab Brain Dis. 2011. PMID: 21881966
-
Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis.PLoS One. 2013 Sep 16;8(9):e73591. doi: 10.1371/journal.pone.0073591. eCollection 2013. PLoS One. 2013. PMID: 24066058 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical